Enhanced recovery after surgery is well established in specialties such as colorectal
surgery. It is achieved through the introduction of multiple evidence-based perioperative …

Lung cancer has a poor prognosis; over half of people diagnosed with lung cancer die
within one year of diagnosis and the 5-year survival is less than 18%. Non-small cell lung …

Introduction Programmed death receptor-1 (PD-1) inhibitors have shown efficacy in first-line
treatment of NSCLC; however, evidence of PD-1 inhibitor as neoadjuvant treatment is …

Lung cancer remains the leading cause of cancer mortality in men and women in the US
and worldwide. About 90% of lung cancer cases are caused by smoking and the use of …

Lung adenocarcinomas (LUAD) that radiologically display as subsolid nodules (SSNs)
exhibit more indolent biological behavior than solid LUAD. The transcriptomic features and …

Background Correctly staging lung cancer is important because the treatment options and
prognosis differ significantly by stage. Several noninvasive imaging studies and invasive …

Lung cancer is the leading cause of cancer-related death and the second most diagnosed
cancer for both men and women in the United States 1, 2 More than 25, 000 surgeries for …

OBJECTIVES Video-assisted thoracoscopic anatomical resections are increasingly used in
Europe to manage primary lung cancer. The purpose of this study was to compare the …

Surgical resection remains the only effective means of cure in the vast majority of patients
with early‐stage lung cancer. It can be performed via a traditional open approach …

Lymph nodes (LNs) are important hubs for metastatic cell arrest and growth, immune
modulation, and secondary dissemination to distant sites through a series of mechanisms …